Mörfelden-Walldorf (dpa/lhe) - The Hessian distribution company for medical cannabis Cansativa is expanding its range. From now on, pharmacies can obtain medical cannabis blossoms from German cultivation from the Canadian manufacturer Aurora via Cansativa, the company announced on Monday in Mörfelden-Walldorf near Frankfurt. "For the first time, we are giving our customers exclusive access to the products of all medical cannabis producers growing in Germany," said Cansativa manager Roland Schneller, according to the announcement.
According to Cansativa, it is the only company in Germany that is allowed to sell medicinal cannabis from local cultivation. In August 2020, it was awarded the contract by the Federal Institute for Drugs and Medical Devices (BfArM). Cansativa has been supplying German-grown cannabis to pharmacies for almost a year.
The company, which employs around 50 people, has previously sold medicinal cannabis from German cultivation by the Canadian manufacturer Tilray and the start-up Demecan, which produces near Dresden. With Aurora, Cansativa will provide 2.6 tons of medicinal cannabis annually over the next four years, it said.
Since July 2021, pharmacies have been able to obtain medical cannabis in pharmaceutical drug quality for the care of patients via the state cannabis agency. Medical cannabis has been permitted in Germany since 2017 and can be prescribed by doctors, for example to relieve pain in the seriously ill. Since then, the drug has experienced a boom. Many start-ups and foreign corporations, such as those from Canada, are bustling about in the growing market.